ID
35814
Beskrivning
Study ID: 102370 (primary study) Clinical Study ID: 102370 Study Title: A multicentre when given according to the 2-4-6 month schedule to healthy infants with booster dose at 12 to 15 months Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00134719 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Haemophilus influenzae Type b, Meningococcal C and Y-Tetanus Toxoid Conjugate Vaccine Trade Name: BIO HIB-MENCY-TT; MenHibrix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis
Nyckelord
Versioner (1)
- 2019-03-25 2019-03-25 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
25 mars 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
GSK Biologicals' Hib-MenCY-TT Conjugate Vaccine vs ActHIB® & MenC Conjugate Licensed Vaccine (NCT00134719)
Study Conclusion
- StudyEvent: ODM
Beskrivning
Follow-Up Studies
Alias
- UMLS CUI-1
- C0016441
Beskrivning
Follow-up Study, Study Subject Participation Status
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0016441
- UMLS CUI [1,2]
- C2348568
Beskrivning
Follow-up Study, Study Subject Participation Status, Reason
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0016441
- UMLS CUI [1,2]
- C2348568
- UMLS CUI [1,3]
- C0566251
Beskrivning
Follow-up Study, Study Subject Participation Status, Reason
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0016441
- UMLS CUI [1,2]
- C2348568
- UMLS CUI [1,3]
- C0566251
Beskrivning
Occurrence of Serious Adverse Event
Alias
- UMLS CUI-1
- C1519255
Beskrivning
Serious Adverse Event, During, Accelerated phase
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0347984
- UMLS CUI [1,3]
- C0457345
Beskrivning
Serious Adverse Event, Count of entities
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0449788
Beskrivning
Elimination Criteria
Alias
- UMLS CUI-1
- C0680251
Beskrivning
Withdrawal
Alias
- UMLS CUI-1
- C2349954
Beskrivning
Patient withdrawn from trial
Datatyp
text
Alias
- UMLS CUI [1]
- C0422727
Beskrivning
Patient withdrawn from trial, Indication
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C3146298
Beskrivning
Patient withdrawn from trial, Indication
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C3146298
Beskrivning
Patient withdrawn from trial, Decision maker
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0679006
Beskrivning
Patient withdrawn from trial, Date last contact
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0805839
Beskrivning
Patient withdrawn from trial, Date last contact, Condition
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0805839
- UMLS CUI [1,3]
- C0348080
Beskrivning
Investigator's Signature
Alias
- UMLS CUI-1
- C2346576
Beskrivning
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Datatyp
text
Alias
- UMLS CUI [1]
- C2346576
Beskrivning
Investigator Signature, Date in time
Datatyp
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Beskrivning
Investigator Name
Datatyp
text
Alias
- UMLS CUI [1]
- C2826892
Similar models
Study Conclusion
- StudyEvent: ODM
C2348568 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,2])
C0457345 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])
C0805839 (UMLS CUI [1,2])
C0805839 (UMLS CUI [1,2])
C0348080 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
Inga kommentarer